In the name of GOD Case presentation Dr

  • Slides: 45
Download presentation
In the name of GOD

In the name of GOD

Case presentation Dr Azar baradaran Resident: Dr behnaz sabaghi

Case presentation Dr Azar baradaran Resident: Dr behnaz sabaghi

19 years boy without past history presents with fatigue, loss of energy and severe

19 years boy without past history presents with fatigue, loss of energy and severe bone pain.

Radiologic study show multiple blastic lesion in bones. In lab data patient had increased

Radiologic study show multiple blastic lesion in bones. In lab data patient had increased ESR.

Panel 1

Panel 1

LCA

LCA

CK

CK

CD 138

CD 138

CD 20

CD 20

CD 10

CD 10

CD 99

CD 99

S 100

S 100

CK 7

CK 7

Ki 67

Ki 67

PLAP

PLAP

TTF 1

TTF 1

CDX 2

CDX 2

Chromogranin

Chromogranin

Step 2

Step 2

Vim

Vim

Melan A

Melan A

PAS

PAS

PAS+diastase

PAS+diastase

Ewing sarcoma/PNET

Ewing sarcoma/PNET

Clinical features ================= Usually ages 5 -20 years. May present with pain, fever, weight

Clinical features ================= Usually ages 5 -20 years. May present with pain, fever, weight loss, leukocytosis and increased erythrocyte sedimentation rate mimicking osteomyelitis.

Sites: marrow of femur, tibia, humerus, fibula, pelvis, ribs, vertebra, mandible, clavicle; may permeate

Sites: marrow of femur, tibia, humerus, fibula, pelvis, ribs, vertebra, mandible, clavicle; may permeate cortex and invade soft tissue.

Radiographic changes ============================= �Cortical thickening and widening of the medullary canal. �With progression of

Radiographic changes ============================= �Cortical thickening and widening of the medullary canal. �With progression of the lesion, reactive periosteal bone may be deposited in layers parallel to the cortex(onion-skin apearance) or at right angles to it (sun-ray appearance)

Typical ill-defined quality, with extensive involvement of medulla and cortex associated with elevation of

Typical ill-defined quality, with extensive involvement of medulla and cortex associated with elevation of periosteum

Microscopic feature: • Solid sheets of cells divided into irregular masses by fibrous strands.

Microscopic feature: • Solid sheets of cells divided into irregular masses by fibrous strands. Individual cells are small and uniform. The nuclei are round, small nucleoli, and variable but usually brisk mitotic activity. • Well-developed vascular network. • Necrosis is common. • May have Homer-Wright rosettes (central fibrillary space) or pseudorosettes (cells arrange themselves around vessels).

Positive stains • CD 99 (O 13, MIC 2), usually PAS+ diastase sensitive (glycogen),

Positive stains • CD 99 (O 13, MIC 2), usually PAS+ diastase sensitive (glycogen), NSE, Leu 7/CD 57, FLI 1 protein, vimentin. • Variable low molecular weight keratin, variable synaptophysin.

Negative stains • S 100, CD 45/LCA, muscle markers, vascular markers.

Negative stains • S 100, CD 45/LCA, muscle markers, vascular markers.

Molecular description • t(11, 22)(q 24; q 12) or t(21; 22)(q 22; q 12)

Molecular description • t(11, 22)(q 24; q 12) or t(21; 22)(q 22; q 12) in 95%. • Fusion of the EWS(Ewing sarcoma) gene at 22 q 12 with the FLI 1 or ERG gene.

Electron microscopy description =========================== Undifferentiated tumor cells with multiple small foci of cytoplasmic glycogen

Electron microscopy description =========================== Undifferentiated tumor cells with multiple small foci of cytoplasmic glycogen are joined by two rudimentary cell junction.

Spread and metastases • The lung and pleura. • Other bones(particulary the skull). •

Spread and metastases • The lung and pleura. • Other bones(particulary the skull). • CNS. • Regional lymph node(rarely). • About 25% of the patients have multiple bone and/or visceral lesion at the time of presentation.

Treatment: Preoperative chemotherapy, surgery, radiation therapy.

Treatment: Preoperative chemotherapy, surgery, radiation therapy.

Poor prognostic factors • Extraosseous location. • Soft tissue extension. • Metastases. • Surgical

Poor prognostic factors • Extraosseous location. • Soft tissue extension. • Metastases. • Surgical margins. • Grossly viable tumor post chemotherapy. • possibly filigree pattern. • Neural differentiation.

 • Type of gene fusion(expect of EWS-FLI 1 type fusion) • Overexpression of

• Type of gene fusion(expect of EWS-FLI 1 type fusion) • Overexpression of TP 53. • MYC. • Deletion of INK 4 a. • Aneuploidy.

Differential diagnosis: • Lymphoblastic lymphoma. • Desmoplastic small cell tumor. • Embryonal/alveolar rhabdomyosarcoma.

Differential diagnosis: • Lymphoblastic lymphoma. • Desmoplastic small cell tumor. • Embryonal/alveolar rhabdomyosarcoma.

Desmoplastic small round cell tumor High grade malignant neoplasm, usually of peritoneum or other

Desmoplastic small round cell tumor High grade malignant neoplasm, usually of peritoneum or other serosal surfaces, rarely in bone or soft tissue.

LYMPHOMA LCA+, TDT+, older patients, polymorphic infiltrate.

LYMPHOMA LCA+, TDT+, older patients, polymorphic infiltrate.

Embryonal/alveolar rhabdomyosarcoma • Loss of cellular cohesion so cells appear to float in alveolar

Embryonal/alveolar rhabdomyosarcoma • Loss of cellular cohesion so cells appear to float in alveolar spaces. • Posive for actin, desmin, myo. D 1.